Search research articles
Contact Us
Filters
Showing results (61-70 of 115) with videos related to
Page
of 12
Sort By:
MMWR. Morbidity and Mortality Weekly Report
|
September 30, 2021
Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021
Anne M Hause, James Baggs, Julianne Gee, et al.
British Journal of Clinical Pharmacology
|
September 20, 2018
Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017
Tiffany A Suragh, Paige Lewis, Jorge Arana, et al.
Human Vaccines & Immunotherapeutics
|
March 28, 2018
Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015
Elaine R Miller, Paige Lewis, Tom T Shimabukuro, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
April 1, 1993
[Expression of proliferating cell nuclear antigen in superficial bladder cancer--application to paraffin-embedded tissue sections]
T Wada, T Shimabukuro, H Kurisu, et al.
Pediatrics
|
February 9, 2017
Safety of Second-Dose Single-Antigen Varicella Vaccine
John R Su, Zanie Leroy, Paige W Lewis, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
November 1, 1987
[Pharmacokinetics of high-dose cisplatin administration (relationship between pharmacokinetics and administration schedule)]
N Yamamoto, K Yanagi, H Matuyama, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
January 1, 1986
[Clinical evaluation of Cernilton in benign prostatic hypertrophy]
J Hayashi, H Mitsui, G Yamakawa, et al.
Public Health Reports (Washington, D.C. : 1974)
|
May 24, 2007
Survey of state practices during the 2004-2005 influenza vaccine shortage
Tom T Shimabukuro, Pascale M Wortley, Barbara Bardenheier, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
June 1, 1993
[Clinical study of sonography and percutaneous nephrostomy in pyonephrosis]
K Ishizu, T Wada, M Yamamoto, et al.
Vaccine
|
November 12, 2021
Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system
Johanna Chapin-Bardales, Tanya Myers, Julianne Gee, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 115) with videos related to
Sort By:
Page
of 12
MMWR. Morbidity and Mortality Weekly Report
|
September 30, 2021
Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021
Anne M Hause, James Baggs, Julianne Gee, et al.
British Journal of Clinical Pharmacology
|
September 20, 2018
Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017
Tiffany A Suragh, Paige Lewis, Jorge Arana, et al.
Human Vaccines & Immunotherapeutics
|
March 28, 2018
Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015
Elaine R Miller, Paige Lewis, Tom T Shimabukuro, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
April 1, 1993
[Expression of proliferating cell nuclear antigen in superficial bladder cancer--application to paraffin-embedded tissue sections]
T Wada, T Shimabukuro, H Kurisu, et al.
Pediatrics
|
February 9, 2017
Safety of Second-Dose Single-Antigen Varicella Vaccine
John R Su, Zanie Leroy, Paige W Lewis, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
November 1, 1987
[Pharmacokinetics of high-dose cisplatin administration (relationship between pharmacokinetics and administration schedule)]
N Yamamoto, K Yanagi, H Matuyama, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
January 1, 1986
[Clinical evaluation of Cernilton in benign prostatic hypertrophy]
J Hayashi, H Mitsui, G Yamakawa, et al.
Public Health Reports (Washington, D.C. : 1974)
|
May 24, 2007
Survey of state practices during the 2004-2005 influenza vaccine shortage
Tom T Shimabukuro, Pascale M Wortley, Barbara Bardenheier, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
June 1, 1993
[Clinical study of sonography and percutaneous nephrostomy in pyonephrosis]
K Ishizu, T Wada, M Yamamoto, et al.
Vaccine
|
November 12, 2021
Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system
Johanna Chapin-Bardales, Tanya Myers, Julianne Gee, et al.
Page
of 12